173 related articles for article (PubMed ID: 18262085)
1. Assessment of external beam radiation technology for dose escalation and normal tissue protection in the treatment of prostate cancer.
D'Ambrosio DJ; Pollack A; Harris EE; Price RA; Verhey LJ; Roach M; Demanes DJ; Steinberg ML; Potters L; Wallner PE; Konski A
Int J Radiat Oncol Biol Phys; 2008 Mar; 70(3):671-7. PubMed ID: 18262085
[No Abstract] [Full Text] [Related]
2. The normal tissue sparing obtained with simultaneous treatment of pelvic lymph nodes and bladder using intensity-modulated radiotherapy.
Søndergaard J; Høyer M; Petersen JB; Wright P; Grau C; Muren LP
Acta Oncol; 2009; 48(2):238-44. PubMed ID: 18759144
[TBL] [Abstract][Full Text] [Related]
3. Role of intensity-modulated radiotherapy in reducing toxicity in dose escalation for localized prostate cancer.
Al-Mamgani A; Heemsbergen WD; Peeters ST; Lebesque JV
Int J Radiat Oncol Biol Phys; 2009 Mar; 73(3):685-91. PubMed ID: 18718725
[TBL] [Abstract][Full Text] [Related]
4. Rectal dose constraints for intensity modulated radiation therapy of the prostate.
Swanson GP; Stathakis S
Am J Clin Oncol; 2011 Apr; 34(2):188-95. PubMed ID: 20622649
[TBL] [Abstract][Full Text] [Related]
5. Hypofractionated intensity-modulated radiotherapy for carcinoma of the prostate: analysis of toxicity.
Coote JH; Wylie JP; Cowan RA; Logue JP; Swindell R; Livsey JE
Int J Radiat Oncol Biol Phys; 2009 Jul; 74(4):1121-7. PubMed ID: 19131179
[TBL] [Abstract][Full Text] [Related]
6. Outcomes of intensity-modulated radiotherapy for prostate cancer using an empty bladder protocol.
Tuan JK; Ha TC; Ong WS; Siow TR; Tham IW; Ng WL; Wang ML; Chua ET; Tan TW
Clin Oncol (R Coll Radiol); 2012 Nov; 24(9):e137-9. PubMed ID: 22795829
[No Abstract] [Full Text] [Related]
7. Prostate cancer: biological dose considerations and constraints in tele- and brachytherapy.
Dörr W; Jaal J; Zips D
Strahlenther Onkol; 2007 Dec; 183 Spec No 2():14-5. PubMed ID: 18166999
[No Abstract] [Full Text] [Related]
8. Intensity-modulated radiotherapy as primary therapy for prostate cancer: report on acute toxicity after dose escalation with simultaneous integrated boost to intraprostatic lesion.
Fonteyne V; Villeirs G; Speleers B; De Neve W; De Wagter C; Lumen N; De Meerleer G
Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):799-807. PubMed ID: 18407430
[TBL] [Abstract][Full Text] [Related]
9. Urinary toxicity after high dose intensity modulated radiotherapy as primary therapy for prostate cancer.
Fonteyne V; Villeirs G; Lumen N; De Meerleer G
Radiother Oncol; 2009 Jul; 92(1):42-7. PubMed ID: 19356817
[TBL] [Abstract][Full Text] [Related]
10. Incidence of late rectal and urinary toxicities after three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for localized prostate cancer.
Zelefsky MJ; Levin EJ; Hunt M; Yamada Y; Shippy AM; Jackson A; Amols HI
Int J Radiat Oncol Biol Phys; 2008 Mar; 70(4):1124-9. PubMed ID: 18313526
[TBL] [Abstract][Full Text] [Related]
11. Dosimetric impact and theoretical clinical benefits of fiducial markers for dose escalated prostate cancer radiation treatment.
Gauthier I; Carrier JF; Béliveau-Nadeau D; Fortin B; Taussky D
Int J Radiat Oncol Biol Phys; 2009 Jul; 74(4):1128-33. PubMed ID: 19147306
[TBL] [Abstract][Full Text] [Related]
12. Dose escalation using a hypofractionated, intensity-modulated radiation therapy boost for localized prostate cancer: preliminary results addressing concerns of high or low alpha/beta ratio.
Shridhar R; Bolton S; Joiner MC; Forman JD
Clin Genitourin Cancer; 2009 Oct; 7(3):E52-7. PubMed ID: 19815482
[TBL] [Abstract][Full Text] [Related]
13. Clinical outcome of adjuvant treatment of endometrial cancer using aperture-based intensity-modulated radiotherapy.
Bouchard M; Nadeau S; Gingras L; Raymond PE; Beaulieu F; Beaulieu L; Fortin A; Germain I
Int J Radiat Oncol Biol Phys; 2008 Aug; 71(5):1343-50. PubMed ID: 18294780
[TBL] [Abstract][Full Text] [Related]
14. Dose-volume relationships for acute bowel toxicity in patients treated with pelvic nodal irradiation for prostate cancer.
Fiorino C; Alongi F; Perna L; Broggi S; Cattaneo GM; Cozzarini C; Di Muzio N; Fazio F; Calandrino R
Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):29-35. PubMed ID: 19467803
[TBL] [Abstract][Full Text] [Related]
15. Hypofractionated intensity-modulated arc therapy for lymph node metastasized prostate cancer.
Fonteyne V; De Gersem W; De Neve W; Jacobs F; Lumen N; Vandecasteele K; Villeirs G; De Meerleer G
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1013-20. PubMed ID: 19386427
[TBL] [Abstract][Full Text] [Related]
16. Hypofractionated accelerated radiotherapy using concomitant intensity-modulated radiotherapy boost technique for localized high-risk prostate cancer: acute toxicity results.
Lim TS; Cheung PC; Loblaw DA; Morton G; Sixel KE; Pang G; Basran P; Zhang L; Tirona R; Szumacher E; Danjoux C; Choo R; Thomas G
Int J Radiat Oncol Biol Phys; 2008 Sep; 72(1):85-92. PubMed ID: 18355982
[TBL] [Abstract][Full Text] [Related]
17. Comparison of biologically equivalent dose-volume parameters for the treatment of prostate cancer with concomitant boost IMRT versus IMRT combined with brachytherapy.
Pieters BR; van de Kamer JB; van Herten YR; van Wieringen N; D'Olieslager GM; van der Heide UA; Koning CC
Radiother Oncol; 2008 Jul; 88(1):46-52. PubMed ID: 18378028
[TBL] [Abstract][Full Text] [Related]
18. The need and prospect of individualized external beam radiotherapy dose escalation beyond 80 gy to treat prostate cancer: in regard to Eade et al. (Int J. Radiat. Oncol. Biol. Phys. 2007;68:682-689).
Cheung MR
Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):645; author reply 645-6. PubMed ID: 18207039
[No Abstract] [Full Text] [Related]
19. Estimated limits of IMRT dose escalation using varied planning target volume margins.
Goulet CC; Herman MG; Hillman DW; Davis BJ
Phys Med Biol; 2008 Jul; 53(14):3777-88. PubMed ID: 18574311
[TBL] [Abstract][Full Text] [Related]
20. Emerging role of intensity-modulated radiation therapy in anorectal cancer.
Meyer JJ; Willett CG; Czito BG
Expert Rev Anticancer Ther; 2008 Apr; 8(4):585-93. PubMed ID: 18402525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]